Human Recombinant VEGF-121, STEMCELL Technologies (CAT#: STEM-CT-0961-ZJF)

Vascular endothelial growth factor (VEGF-121) is a naturally-occurring VEGF-A splice variant involved in embryonic vasculogenesis and angiogenesis. VEGF binds to VEGFR-1 and VEGFR-2, and activates Raf/MEK/ERK and PI3K/AKT pathways. VEGF-121 is released as a freely diffusible protein by a variety of normal and transformed cells. It plays an important role in neurogenesis both in vitro and in vivo (Storkebaum et al.). It has neurotrophic effects on neurons of the central nervous system and promotes growth and survival of dopaminergic neurons and astrocytes. VEGF also promotes growth and survival of vascular endothelial cells, monocyte chemotaxis, and colony formation by granulocyte-macrophage progenitor cells (Ferrara et al.).

Subtype: Cytokines, Growth Factors
Cell Type: Angiogenic Cells, Endothelial Cells, Hematopoietic Stem and Progenitor Cells, Mesenchymal Stem and Progenitor Cells, Mesoderm, PSC-Derived, Neural Stem and Progenitor Cells, Pluripotent Stem Cells
Species: Human
Area of Interest: Angiogenic Cell Research, Endothelial Cell Biology, Neuroscience, Stem Cell Biology
Purity: ≥ 95%

Reliable Consistency: Guarantees uniformity and repeatability in various applications with endotoxin levels below 0.2 EU/μg.
Free of Animal Components: Completely devoid of any animal or human-derived elements.
Broad Selection: Offers a wide range of human, mouse, and rat cytokines available in multiple sizes.

Human Recombinant TNF-beta, STEMCELL Technologies
Human Recombinant TPO, STEMCELL Technologies
Human Recombinant VEGF-165, STEMCELL Technologies
Human Recombinant VEGF-165, ACF, STEMCELL Technologies